ReGenX Biosciences
Pre-clinicalA biotechnology company developing gene therapies using its proprietary NAV Technology Platform for rare diseases.
Founded
2009
Focus
BiologicsDrug DeliveryRNA & Gene Therapy
About
A biotechnology company developing gene therapies using its proprietary NAV Technology Platform for rare diseases.
Funding History
3Total raised: $235M
Series C$75MViking Global InvestorsDec 15, 2022
Series B$95MViking Global InvestorsJun 15, 2021
Series A$65MViking Global InvestorsJan 15, 2020
Company Info
TypePrivate
Founded2009
LocationRockville, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile